Cargando…
Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas: A meta-analysis
BACKGROUND: The high pretreatment plasma fibrinogen has been widely reported to be a possible biomarker for predicting prognosis in hepatocellular carcinoma (HCC) and pancreatic carcinoma (PC), but persuasive conclusion has not been made yet. Thus, we herein conducted a meta-analysis to comprehensiv...
Autores principales: | Ji, Rui, Ren, Qian, Bai, Suyang, Wang, Yuping, Zhou, Yongning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023750/ https://www.ncbi.nlm.nih.gov/pubmed/29923974 http://dx.doi.org/10.1097/MD.0000000000010824 |
Ejemplares similares
-
The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis
por: Song, Haifeng, et al.
Publicado: (2019) -
Prognostic value of plasma fibrinogen in hepatocellular carcinoma: a meta-analysis
por: Huang, Guanqun, et al.
Publicado: (2018) -
Prognostic value of pretreatment plasma fibrinogen in patients with colorectal cancer: A systematic review and meta-analysis
por: Li, Menglei, et al.
Publicado: (2019) -
Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer
por: Zhang, Yi, et al.
Publicado: (2020) -
Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer
por: Holzinger, Daniel, et al.
Publicado: (2016)